CIDRAP newsletters options
The pace of outbreaks in poultry has slowed dramatically since December.
Whether naturally acquired or introduced, segmented filamentous bacteria protected mice against flu, RSV, and SARS-CoV-2 infection.
Only 5% of participants across all studies said they had concealed a COVID-19 infection.
CDC guidance was based on droplet dogma rather than the current view that SARS-CoV-2 spreads primarily through aerosols, the authors said.
The virus was confirmed in gentoo penguins, with a suspected detection in king penguins from another location in the region.
People with rheumatologic autoimmune diseases and HIV had an only slightly elevated mortality risk compared to immunocompetent patients.
An investigation of the clinic identified gaps in environmental cleaning practices, surgical device disinfection.
The disease was confirmed in a buck mule deer in Deer Hunt Area 90 in December.
GSK has applied for expanded RSV vaccine use in adults ages 50 to 59 who have underlying health conditions.
The country has now confirmed 8 such cases since early 2023.
In 1 study, only 25% of patients tested positive on PCR tests for 21 days or longer after onset of illness.
No invasive cervical cancer cases were seen in women vaccinated against HPV at age 12 or 13 in Scotland, regardless of the number of doses.
The patients are from the same district, and both had consumed raw date juice, a known risk factor.
Trends favoring QIV-HD versus QIV-SD were observed over time, even before the flu season was under way.
Among the exposures the study will evaluate is antibiotic use, which has been shown to disrupt the microbiome.
The findings highlight the need to boost infection prevention and control and antimicrobial stewardship efforts in Greek hospitals.
More than half (53.5%) of patients with PCC had a response speed slower than 2 standard deviations from the control mean.
In a preliminary flu season severity assessment, the CDC said the season has been moderate.
Though quarter 1 of 2020 saw the highest exit rate, the percentage remained high throughout the study period.
A simulation estimated that reallocating COVID-19 treatment based on risk for severe infection would have prevented 16,500 COVID-related deaths.
